Proteome Sciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure7.7yrs
Board average tenure10.5yrs

Recent management updates

Here's Why Shareholders Should Examine Proteome Sciences plc's (LON:PRM) CEO Compensation Package More Closely

May 10
Here's Why Shareholders Should Examine Proteome Sciences plc's (LON:PRM) CEO Compensation Package More Closely

Recent updates

Here's Why Shareholders Should Examine Proteome Sciences plc's (LON:PRM) CEO Compensation Package More Closely

May 10
Here's Why Shareholders Should Examine Proteome Sciences plc's (LON:PRM) CEO Compensation Package More Closely

Here's Why We Think Proteome Sciences (LON:PRM) Is Well Worth Watching

Dec 02
Here's Why We Think Proteome Sciences (LON:PRM) Is Well Worth Watching

Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Aug 25
Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Dec 22
Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Do Proteome Sciences' (LON:PRM) Earnings Warrant Your Attention?

Sep 03
Do Proteome Sciences' (LON:PRM) Earnings Warrant Your Attention?

Calculating The Fair Value Of Proteome Sciences plc (LON:PRM)

Jan 27
Calculating The Fair Value Of Proteome Sciences plc (LON:PRM)

Does Proteome Sciences (LON:PRM) Deserve A Spot On Your Watchlist?

May 31
Does Proteome Sciences (LON:PRM) Deserve A Spot On Your Watchlist?

Some Confidence Is Lacking In Proteome Sciences plc's (LON:PRM) P/E

Apr 04
Some Confidence Is Lacking In Proteome Sciences plc's (LON:PRM) P/E

CEO

Proteome Sciences has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Christopher Donovan Pearce
Executive Chairman30.6yrsUK£62.00k12.51%
£ 1.6m
Ian Pike
Chief Scientific Officer & Executive Director8.2yrsUK£245.00k0.056%
£ 7.1k
Richard Dennis
Chief Commercial Officer & Executive Director7.8yrsUK£207.00k0.21%
£ 26.9k
Victoria Birse
Company Secretary7.5yrsno datano data

7.7yrs

Average Tenure

66yo

Average Age

Experienced Management: PRM's management team is seasoned and experienced (7.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Christopher Donovan Pearce
Executive Chairman30.6yrsUK£62.00k12.51%
£ 1.6m
Ian Pike
Chief Scientific Officer & Executive Director14.3yrsUK£245.00k0.056%
£ 7.1k
Richard Dennis
Chief Commercial Officer & Executive Director6.8yrsUK£207.00k0.21%
£ 26.9k
Denis Hochstrasser
Member of the Scientific Advisory Boardno datano datano data
Roger McDowell
Independent Non Executive Director10.6yrsUK£35.00k1.15%
£ 146.2k
William Dawson
Chairman of Scientific Advisory Boardno dataUK£16.00kno data
Jean-Charles Sanchez
Member of the Scientific Advisory Boardno datano datano data
Brian Anderton
Member of the Scientific Advisory Boardno datano datano data
Ursula Ney
Independent Non-Executive Director7.5yrsUK£33.00kno data
Julian Duncan
Member of Scientific Advisory Boardno datano datano data
Martin Diggle
Non-Executive Director10.3yrsno datano data

10.5yrs

Average Tenure

67.5yo

Average Age

Experienced Board: PRM's board of directors are seasoned and experienced ( 10.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/15 14:15
End of Day Share Price 2025/02/14 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Proteome Sciences plc is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCavendish
Navid MalikCavendish Historical (Cenkos Securities)
Michael Thomas CooperEdison Investment Research